PRLD Earnings

Quarterly EPS
$-0.43
Q3 2024
$-0.38
Q4 2024
$-0.42
Q1 2025
$-0.41
Q2 2025
$-0.26
Q3 2025
$-0.21
Q4 2025
$-0.13
Q1 2026
$-0.14
Q2 2026
Latest Revenue5.7M
Latest Net Income-13921000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.145.7M-13921000+65.9%
Q1 2026-$0.134.6M-10385000+69.0%
Q4 2025-$0.215.6M-16457000+41.0%+44.7%
Q3 2025-$0.266.5M-19725000+116.7%+39.5%
Q2 2025-$0.410-31231000+10.9%
Q1 2025-$0.420-32085000+0.0%
Q4 2024-$0.384.0M-28731000+19.1%
Q3 2024-$0.433.0M-32271000+4.4%
Q2 2024-$0.460-34740000
Q1 2024-$0.420-31431000
Q4 2023-$0.470-33075000
Q3 2023-$0.450-30608000
Prelude Therapeutics (PRLD) — Earnings